References
- Bain B, Pierre R, Imbert M, Vardiman J W, Brunning R D, Flandrin G. Chronic eosinophilic leukaemia and the hypereosinophilic syndrome. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, E S Jaffe, N L Harris, H Stein, J W Vardiman. IARC Press, Lyon 2001; 29–31
- Cools J, DeAngelo D J, Gotlib J, Stover E H, Legare R D, Cortes J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003; 348: 1201–1214
- Bain B J. Relationship between idiopathic hypereosinophilic syndrome, eosinophilic leukaemia and systemic mastocytosis. Am J Hematol 2004; 77: 82–85
- Bain B J. Cytogenetic and molecular genetic aspects of eosinophilic leukaemia. Br J Haematol 2003; 122: 173–179
- Gotlib J. Molecular classification and pathogenesis of eosinophilic disorders: 2005 update. Acta Haematol 2005; 114: 7–25
- Kobayashi H, Kitano K, Shimodaira S, Ishida F, Saito H, Sonoyama M, et al. Eosinophilia in myelodysplastic syndrome with a (12;21)(q23;q22) translocation. Cancer Genet Cytogenet 1993; 68: 95–98
- Pérez-Losada A, Woessner S, Sol F, Florensa L, Granena A. Refractory anaemia with hypereosinophilia and clonal abnormal metaphases detected in the neutrophilic granulopoietic series. Acta Haematol 1994; 91: 80–83